Catailyst Financing Snippet: Series B, #VC financing $157M Engrail Therapeutics #CNS #Neuro catailyst.ai/BWN/67643/Engr…

Catailyst Regulatory Event Snippet: Rare Pediatric Disease Designation Treatment of Osteosarcoma LSTA1 is an investigational drug Lisata Therapeutics catailyst.ai/GLN/54666/Lisa…

Financing Snippet: (Snippets are delivered to your mailbox) $NKTX PublicOffering (Pricing) Nkarta, Inc. Offering Size: $240.1 million Joint bookrunners: SVB Leerink, TDCowen , Stifel and Mizuho catailyst.ai/GLN/54788/Nkar…

Catailyst AI Engine processes 500+ press releases daily to ensure your team has the clinical & regulatory event info they need. Human can process only a handful news. Stay informed. #ClinicalTrials #MedTech #AI Try it here: catailyst.ai/registration

BioPharma/Life Science Follow-on Offerings 105 Offerings, >$10B Average $97M Median $53M 37 Offerings > $50M Average $254M, Median $190M Driven by Clinical & Regulatory Positive Results/Outcome

Clinical trial results and approvals are driving Follow-on public offerings Q1 2024 Follow on public offering

Catailyst 2.0 is here! catailyst.ai/home

Top ADC associated Events in 2024 Catailyst, Life Science Data , Alerts & Visuals , Inc.'s "ai engine" has analyzed 70,000+ press releases since January 2024, pinpointing 185 significant events linked to Antibody Drug Conjugates. Merck Receives Positive EU CHMP Opinion catailyst.ai/news/BWN-72518

Top ADC associated Events in 2024 Catailyst, Life Science Data , Alerts & Visuals 's "ai engine" has analyzed 70,000+ press releases since January 2024, pinpointing 185 significant events linked to ADCs. AstraZeneca & Daiichi Sankyo, ENHERTU approval catailyst.ai/news/BWN-70778 catailyst.ai/news/BWN-68335

Top ADC associated Events in 2024 Catailyst, Life Science Data , Alerts & Visuals "ai engine" has analyzed 70,000+ press releases since January 2024, pinpointing 185 significant events linked to ADCs. Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA catailyst.ai/news/BWN-71686

Top ADC associated Events in 2024 Catailyst, Life Science Data , Alerts & Visuals "ai engine" has analyzed 70,000+ press releases since January 2024, pinpointing 185 significant events linked to ADCs. RemeGen Biosciences's RC88 Obtained FDA Fast Track Designation catailyst.ai/news/PRN-429318

Top ADC associated Events in 2024 Catailyst, Life Science Data , Alerts & Visuals "ai engine" has analyzed 70,000+ press releases since January 2024, pinpointing 185 significant events linked to ADCs. FibroGen, Inc. Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 catailyst.ai/news/GLN-55235

Top ADC associated Events in 2024 Catailyst, Life Science Data , Alerts & Visuals "ai engine" has analyzed 70,000+ press releases since January 2024, pinpointing 185 significant events linked to ADCs. @ProfoundBio inatabart Sesutecan FDA Fast Track Designation for Advanced Ovarian Cancer catailyst.ai/news/PRN-425674

Hamlet, Hansa Biopharma positive topline results from the US Phase 3 ConfIdeS trial of imlifidase, showing a statistically significant and clinically meaningful difference in kidney function at 12 mons compared to the control arm, met its primary endpoint and was well-tolerated.

Picard Medical, Inc. has strengthened its intellectual property portfolio with the grant of U.S. Patent No. 12,383,722 B2, covering its next-generation SynCardia Total Artificial Heart.

Lexicon Pharmaceuticals has submitted additional clinical data from ongoing third-party funded studies to the FDA for Zynquista, an oral SGLT1/SGLT2 inhibitor for type 1 diabetes. $LXRX

2025 Biopharma Financing Timeline: Q3 Update is HERE.catailyst.ai/home A deep dive into the latest VC rounds, IPO activity, and public follow-ons through the third quarter. The capital markets are evolving—see where the smart money is moving now. #Catailyst

Biopharma VC financing from 2024 to Q3 2025 reached approximately $22.7 billion across 387 deals. The investment landscape is heavily concentrated, with California and Massachusetts dominating the capital and deal volume. Series A rounds recorded the highest number of deals.

Catailyst Trending Topics Jade Biosciences secures $$$135M in PIPE financing to fuel development of #autoimmune disease treatments. Find more here - catailyst.ai/home

@Trogenix raises $95M in #SeriesA to advance curative cancer therapies via its #Odysseus platform. Investors: IQ Capital , 4BIO Capital, Cancer Research Horizons, the National Brain Tumor Society, Eli Lilly and Company , Meltwind , LongeVC Calculus Capital